instead of the usual auto-injector pen the drug comes in. Eli Lilly isn’t alone in adopting direct-to-consumer strategies. Pfizer (PFE) launched a similar service, PfizerforAll, this summer ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
We are very confident with both the auto-injectors and the vials that we will be able to supply the needs in the US ...
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest ... In this photo is a Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday ...
On December 19, 2024, the FDA removed tirzepatide injection from its shortage list after slightly over two years. Tirzepatide is the active ingredient of Eli Lilly’s Mounjaro and Zepbound, two ...